Results from feeding trials have shown that inclusion of Calanus® Hydrolysate enhances growth and survival in early life stages of aquatic animal species, which is in harmony with the ecological role of the copepod Calanus finmarchicus as a natural starter feed for marine fish and shrimp larvae. Calanus AS has now secured funding from MABIT (Marine Biotechnology in Tromsø), for a project total of 1.65 million NOK, to investigate the bioactive, growth-promoting compounds of the product in collaboration with scientists from the research institute Nofima.
The aim of the forthcoming project is to demonstrate that the observed improved growth rate can be attributed to specialized classes of peptides in Calanus® Hydrolysate. Growth-promoting bioactive peptides can be identified with the combined use of bioassay-guided fractionation and muscle cell culture studies, screening for bioactivity in both salmon and bovine cells. Furthermore, a detailed characterization of the identified bioactive peptides can be made by sequencing using mass spectrometry analysis. This is expected to result in well-characterized peptides which document the bioactive properties of Calanus® Hydrolysate.